News & AnalysisBiomedicine

NIH's Secondhand Shop for Tried-and-Tested Drugs

Science  24 Jun 2011:
Vol. 332, Issue 6037, pp. 1492
DOI: 10.1126/science.332.6037.1492

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Although the U.S. National Institutes of Health (NIH) has made waves with a proposed new center aimed at translational research, so far the main innovation has been to put scattered existing programs under the same roof. But this month NIH Director Francis Collins unveiled something fresh: an effort to persuade drug companies to open up their troves of abandoned drugs to academics, who would look for new uses.